AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Thérapie

Results: 1-25/878

Authors: Souvignet, C Zarski, JP
Citation: C. Souvignet et Jp. Zarski, Gene therapy approaches in chronic viral hepatitis, THERAPIE, 55(3), 2000, pp. 333-341

Authors: Le Bars, M Glowinski, J Bannwarth, B
Citation: M. Le Bars et al., Experimental and clinical aspects of opioid tolerance, physical dependenceand addiction, THERAPIE, 55(3), 2000, pp. 343-347

Authors: Vandel, P Haffen, E Vandel, S Bonin, B Sechter, D Bizouard, P Dalery, J
Citation: P. Vandel et al., Drug extrapyramidal side-effects or not: is there a dextromethorphan phenotype difference?, THERAPIE, 55(3), 2000, pp. 349-353

Authors: Attitallah, S Berard, M Belkahia, C Bechtel, YC Bechtel, PR
Citation: S. Attitallah et al., Similarities and/or dissimilarities of CYP2D6 polymorphism in three Tunisian ethnic groups: Arabs, Berbers, Numides, THERAPIE, 55(3), 2000, pp. 355-360

Authors: Attitallah, S Bechtel, YC Belkahia, C Bechtel, PR
Citation: S. Attitallah et al., Analysis of N-acetyltransferase (NAT(2)) in three ethnic groups in Tunisia, THERAPIE, 55(3), 2000, pp. 361-369

Authors: Alliot, C Barrios, M Tabuteau, S Desablens, B
Citation: C. Alliot et al., Autoimmune cytopenias associated with malignancies and successfully treated with intravenous immune globulins: about two cases, THERAPIE, 55(3), 2000, pp. 371-374

Authors: Berrada, Y Settaf, A Baddouri, K Cherrah, A Hassar, M
Citation: Y. Berrada et al., Experimental assessment of antihypertensive and hypolipidemic effects of oil of Argan, Argania sideroxylon, THERAPIE, 55(3), 2000, pp. 375-378

Authors: Zaoui, A Cherrah, Y Lacaille-Dubois, MA Settaf, A Amarouch, H Hassar, M
Citation: A. Zaoui et al., Diuretic and hypotensive effects of Nigella sativa on the spontaneously hypertensive rat, THERAPIE, 55(3), 2000, pp. 379-382

Authors: Laure, P
Citation: P. Laure, Performance-enhancing drugs use by medical students in Nancy (France), THERAPIE, 55(3), 2000, pp. 383-389

Authors: Pelagatti, V Bagheri, H Fernandez, P Railhac, N Bregeon, C Railhac, JJ Montastruc, JL
Citation: V. Pelagatti et al., Adverse drug effects of iodinated contrast agents: a six-month study in a radiology department, THERAPIE, 55(3), 2000, pp. 391-394

Authors: Remy, N Lapeyre-Mestre, M Bareille, MP Bagheri, H Montastruc, JL
Citation: N. Remy et al., Drug interactions: a prospective pilot study in primary health care, THERAPIE, 55(3), 2000, pp. 395-398

Authors: Hassoun, S Pisante, L Cattan, S Nallet, O Jarousse, B Jeantils, V Rosenheim, M Zemour, G Fauvelle, F
Citation: S. Hassoun et al., Myocardial infarction and angina with protease inhibitors: 4 cases, THERAPIE, 55(3), 2000, pp. 399-402

Authors: Sadeg, N Deschamps, P Jacoly, C Dumontet, M
Citation: N. Sadeg et al., Urapidil, bromazepam and chlorpromazine poisoning: a case report, THERAPIE, 55(3), 2000, pp. 402-404

Citation: 4th National Congress of French Society of Pharmacology, Rouen 10-12 April2000: Abstracts of pharmacovigilance presentations - Abstracts, THERAPIE, 55(3), 2000, pp. 405-431

Authors: Boudes, P Bailly, G
Citation: P. Boudes et G. Bailly, Endocrinology of oestrogens: recent developments and future applications, THERAPIE, 55(2), 2000, pp. 237-247

Authors: Lory, P Monteil, A Chemin, J Leuranguer, V Bourinet, E Nargeot, J
Citation: P. Lory et al., Molecular diversity of voltage-gated calcium channels, THERAPIE, 55(2), 2000, pp. 249-254

Authors: Angelico, F Hurtova, M
Citation: F. Angelico et M. Hurtova, Therapeutics teaching: problems in prescribing long-term treatment for chronic diseases, THERAPIE, 55(2), 2000, pp. 255-258

Authors: Consoli, SM Troy, S Bernaud, C
Citation: Sm. Consoli et al., Quality of life in hypertensive patients treated by prazosin (sustained release) or enalapril: a randomized double blind trial over 24 weeks, THERAPIE, 55(2), 2000, pp. 259-267

Authors: Fauvelle, F Petitjean, O Tod, M Guillevin, L
Citation: F. Fauvelle et al., Clinical pharmacokinetics during plasma exchange, THERAPIE, 55(2), 2000, pp. 269-275

Authors: Cabelguenne, D Bleyzac, N Pivot, C Maire, P
Citation: D. Cabelguenne et al., Can we use a Bayesian method to build a pharmacokinetic population in two steps?, THERAPIE, 55(2), 2000, pp. 277-282

Authors: Machet, G Coudray, JM
Citation: G. Machet et Jm. Coudray, Lactic acidosis and implicated metformin: why better information about risk factors?, THERAPIE, 55(2), 2000, pp. 283-294

Authors: Bouley, M Viriot, E Barache, D
Citation: M. Bouley et al., Practical reflections on the misuse of drugs, THERAPIE, 55(2), 2000, pp. 295-301

Authors: Roch-Torreilles, I Camu, W Hillaire-Buys, D
Citation: I. Roch-torreilles et al., Safety profile of riluzole (Rilutek (R)) in the treatment of amyotrophic lateral sclerosis, THERAPIE, 55(2), 2000, pp. 303-312

Authors: Amedee-Manesme, O
Citation: O. Amedee-manesme, Strategic analysis and the pharmaceutical industry, THERAPIE, 55(2), 2000, pp. 313-317

Authors: Andre, M Fialip, J Zenut, M Aumaitre, O Eschalier, A
Citation: M. Andre et al., Mental disorder associated with proton pump inhibitors and benzodiazepines: three cases, THERAPIE, 55(2), 2000, pp. 319-320
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>